查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494772

到 2030 年骨生長刺激器市場預測：按產品類型、分銷管道、應用、最終用戶和地區進行的全球分析

Bone Growth Stimulators Market Forecasts to 2030 - Global Analysis By Product Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球骨生長促效劑市場規模為 23 億美元，預計在預測期內將以 12.1% 的複合年成長率成長，到 2030 年達到 46 億美元。

骨骼生長刺激器是醫療設備。對骨折或骨癒合部位施加電或超音波刺激，以促進新骨組織的形成。當骨骼癒合緩慢或有阻止正常骨骼生長的疾病時，該技術特別有用。透過加速癒合過程，骨骼生長刺激器可以縮短恢復時間，最大限度地減少併發症，並改善骨折、骨不連和其他骨骼相關損傷和病症患者的整體預後。

根據《世界人口展望》2019 年修訂數據，2019 年，每 11 人中就有 1 人年齡在 65 歲或以上。到 2050 年，這一數字預計將上升至六分之一。

骨折和骨質疏鬆症增加

由於擔心骨折和骨質疏鬆症患者數量不斷增加，市場需求激增。這種趨勢在人口老化中尤其明顯，凸顯了對有效治療方案的需求。隨著老齡化，骨骼密度下降，使我們更容易發生骨折和骨質疏鬆症相關併發症。因此，人們對促進骨癒合和再生的骨生長促效劑的信心不斷增強，從而推動了市場的成長。

潛在的副作用

該市場的突出特點是潛在副作用方面的挑戰。確保安全性和有效性，同時最大限度地減少副作用仍然是一個關鍵問題。常見的副作用包括刺激部位的皮膚刺激、不適和罕見的過敏反應。此外，需要徹底的監測和監管，以解決組織損傷和骨不連等長期影響。平衡創新和安全措施對於該行業的信心和市場生存至關重要。

脊椎融合手術增加

市場需求激增，特別是由於脊椎融合手術的普及普及。這一趨勢是由多種因素推動的，包括人口老化、脊椎疾病的增加以及醫療技術的進步。因此，骨骼生長刺激器的採用顯著增加，特別是在脊椎融合手術中。這是因為醫療保健專業人員正在尋找有效的方法來提高骨癒合和固定率，最終改善患者的治療效果。

設備高成本

該市場的特點是設備成本高，這是許多患者進入該市場的主要障礙。這些旨在幫助骨癒合和再生的設備通常價格昂貴，限制了可用性和負擔能力。儘管它們在加速康復和改善骨折和整形外科疾病的預後方面具有潛在的好處，但與這些刺激器相關的高成本阻礙了公平地獲得這一重要的醫療技術，這是這樣做的一個挑戰。

COVID-19 的影響：

COVID-19 的爆發對骨生長促效劑市場產生了重大影響。由於這些醫療資源被用於危機管理，包括整形外科手術在內的選擇性手術面臨延誤，影響了對骨生長促效劑的需求。此外，供應鏈中斷和經濟不確定性阻礙了市場成長。然而，隨著醫療保健系統的穩定和手術的恢復，由於整形外科疾病盛行率的上升和骨刺激技術的進步，市場預計將逐漸復甦。

脊椎融合手術部分預計將成為預測期內最大的部分

脊椎融合手術預計將成為預測期內最大的部分。隨著脊椎融合手術領域的增加，對這些刺激器的需求也增加。技術進步、老年人口增加和脊椎疾病流行等因素正在推動市場擴張。此外，有利的報銷政策和不斷提高的患者意識進一步促進了市場成長，使其成為醫療設備業內一個充滿希望的領域。

醫院和診所領域預計在預測期內複合年成長率最高

醫院和診所產業預計在預測期內複合年成長率最高。這些設施利用最尖端科技，包括電磁和超音波骨骼生長刺激器，提供從診斷到治療的全面護理。透過專注於以患者為中心的護理，醫院和診所正在確保有效的康復和康復，推動骨生長促效劑市場的成長，並改善患有骨相關疾病的患者的治療結果。

比最大的地區

由於整形外科疾病數量不斷增加和人口老化，預計北美在預測期內將佔據最大的市場佔有率。醫療設備的技術進步，加上患者和醫療保健專業人員對骨生長促效劑益處的認知不斷提高，進一步推動了市場擴張。此外，有利的報銷政策和醫療基礎設施投資也有助於市場擴張。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率。骨骼生長刺激技術的不斷進步正在導致更有效和高效的設備的開發。世界各國政府正在採取舉措改善醫療基礎設施並加速先進醫療技術的採用。這包括努力減輕肌肉骨骼疾病的負擔和改善患者的治療結果。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球骨生長刺激器市場：依產品類型

  • 骨骼生長促效劑
    • 電容耦合裝置
    • 組合磁場裝置
    • 植入式骨生長刺激器
    • 超音波骨刺激器
  • 骨形成蛋白（BMP）
  • 血小板衍生生長因子 (PDGF)
  • 其他產品類型

第6章全球骨生長刺激器市場：按分銷管道

  • 直銷
  • 代理銷售
  • 網路零售商
  • 藥局/專賣店

第7章全球骨生長刺激器市場：按應用

  • 斷裂
  • 脊椎融合手術
  • 牙科和顎顏面
  • 骨關節炎和骨質疏鬆症
  • 軟組織修復
  • 其他用途

第8章全球骨生長刺激器市場：依最終用戶分類

  • 醫院和診所
  • 日間手術中心 (ASC)
  • 居家照護環境
  • 其他最終用戶

第9章全球骨生長刺激器市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Orthologic Corp.
  • Medtronic plc
  • Harvest Technologies Corp.
  • Amedica Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • Orthofix Medical Inc.
  • Bone Solutions Inc.
  • Bioventus LLC
  • Arthrex, Inc.
  • Isto Technologies, Inc.
  • Stryker Corporation
Product Code: SMRC26287

According to Stratistics MRC, the Global Bone Growth Stimulators Market is accounted for $2.3 billion in 2024 and is expected to reach $4.6 billion by 2030 growing at a CAGR of 12.1% during the forecast period. Bone growth stimulators are medical devices designed to enhance the natural healing process of bones. They work by applying electrical or ultrasound stimulation to the site of a fracture or a bone fusion, promoting the formation of new bone tissue. This technology is particularly useful in cases where bones are slow to heal or when there are conditions that hinder normal bone growth. By accelerating the healing process, bone growth stimulators can reduce recovery time, minimize complications, and improve overall outcomes for patients with fractures, non-unions, or other bone-related injuries or conditions.

According to the World Population Prospects, 2019 Revision Data, 1 in 11 people in 2019 were over the age of 65. This figure is expected to rise to one in every six people by 2050.

Market Dynamics:

Driver:

Rising incidence of bone fractures and osteoporosis

The market has witnessed a surge in demand owing to a concerning rise in bone fractures and osteoporosis cases. This trend, particularly prevalent in aging populations, underscores the need for effective treatment options. As individuals age, bone density decreases, increasing susceptibility to fractures and osteoporosis-related complications. Consequently, there's a growing reliance on bone growth stimulators to facilitate bone healing and regeneration, driving market growth.

Restraint:

Potential side effects

In the market, challenges related to potential side effects loom prominently. Ensuring safety and efficacy while minimizing adverse reactions remains a critical concern. Common side effects include skin irritation at the stimulation site, discomfort, and rare cases of allergic reactions. Moreover, there's a need for thorough monitoring and regulatory oversight to address long-term impacts, such as tissue damage or bone nonunion. Balancing innovation with safety measures is paramount for sustaining trust and market viability in this field.

Opportunity:

Increasing number of spinal fusion surgeries

The market has witnessed a surge in demand, notably attributed to the increasing prevalence of spinal fusion surgeries. This trend is fueled by various factors such as aging populations, rising incidences of spinal disorders, and advancements in medical technology. Consequently, there has been a notable uptick in the adoption of bone growth stimulators, particularly in spinal fusion procedures, as healthcare professionals seek effective methods to enhance bone healing and fusion rates, ultimately improving patient outcomes.

Threat:

High cost of devices

The market is marked by the high cost of devices, posing a significant barrier to access for many patients. These devices, designed to aid in bone healing and regeneration, often come with substantial price tags, limiting their availability and affordability. Despite their potential benefits in accelerating recovery and improving outcomes for fractures and orthopedic conditions, the steep costs associated with these stimulators present challenges in ensuring equitable access to this crucial medical technology.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the Bone Growth Stimulators market. With these healthcare resources redirect towards managing the crisis, elective procedures, including orthopedic surgeries, faced delays, affecting the demand for bone growth stimulators. Additionally, supply chain disruptions and economic uncertainties hindered market growth. However, as healthcare systems stabilize and surgeries resume, the market is expected to recover gradually, driven by the rising prevalence of orthopedic conditions and advancements in bone stimulation technology.

The spinal fusion segment is expected to be the largest during the forecast period

The spinal fusion is expected to be the largest during the forecast period. With an increasing number of spinal fusion procedures globally, the demand for these stimulators is escalating. Factors such as technological advancements, rising geriatric population, and the prevalence of spinal disorders are driving market expansion. Additionally, favorable reimbursement policies and growing awareness among patients are further contributing to market growth, making it a promising sector within the medical devices industry.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period. These facilities provide comprehensive care, from diagnosis to therapy, leveraging cutting-edge technologies such as electromagnetic and ultrasound bone growth stimulators. With a focus on patient-centered care, hospitals and clinics ensure effective rehabilitation and recovery, driving the growth of the bone growth stimulators market and improving outcomes for individuals with bone-related ailments.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing incidences of orthopedic conditions and a rising aging population. Technological advancements in medical devices, coupled with growing awareness among patients and healthcare professionals regarding the benefits of bone growth stimulators, are further fueling market expansion. Additionally, favorable reimbursement policies and investments in healthcare infrastructure contribute to market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. Continuous advancements in bone growth stimulation technology have led to the development of more effective and efficient devices. Governments in various countries are taking initiatives to improve healthcare infrastructure and promote the adoption of advanced medical technologies. This includes initiatives to reduce the burden of musculoskeletal disorders and improve patient outcomes.

Key players in the market

Some of the key players in Bone Growth Stimulators market include Orthologic Corp., Medtronic plc, Harvest Technologies Corp., Amedica Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Orthofix Medical Inc., Bone Solutions Inc., Bioventus LLC, Arthrex, Inc., Isto Technologies, Inc., Stryker Corporation.

Key Developments:

In December 2023, Orthofix Medical Inc. announced the new data that supported the safety and efficacy of PEMF Stimulation in Lumbar Spine Fusion Procedures indicated for patients with the risk of pseudarthrosis.

In February 2022, Orthofix Medical Inc. introduced a new synthetic bioactive bone graft solution called Opus B.A., which is used for cervical and lumbar spine fusion procedures.

Product Types Covered:

  • Bone Growth Stimulation Devices
  • Bone Morphogenetic Proteins (BMPs)
  • Platelet-Derived Growth Factor (PDGF)
  • Other product Types

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Retailers
  • Pharmacies and Specialty Stores

Applications Covered:

  • Fractures
  • Spinal Fusion
  • Dental and Maxillofacial
  • Osteoarthritis and Osteoporosis
  • Soft Tissue Repair
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bone Growth Stimulators Market, By Product Type

  • 5.1 Introduction
  • 5.2 Bone Growth Stimulation Devices
    • 5.2.1 Capacitive Coupling Devices
    • 5.2.2 Combined Magnetic Field Devices
    • 5.2.3 Implantable Bone Growth Stimulators
    • 5.2.4 Ultrasonic Bone Stimulators
  • 5.3 Bone Morphogenetic Proteins (BMPs)
  • 5.4 Platelet-Derived Growth Factor (PDGF)
  • 5.5 Other product Types

6 Global Bone Growth Stimulators Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Direct Sales
  • 6.3 Distributors
  • 6.4 Online Retailers
  • 6.5 Pharmacies and Specialty Stores

7 Global Bone Growth Stimulators Market, By Application

  • 7.1 Introduction
  • 7.2 Fractures
  • 7.3 Spinal Fusion
  • 7.4 Dental and Maxillofacial
  • 7.5 Osteoarthritis and Osteoporosis
  • 7.6 Soft Tissue Repair
  • 7.7 Other Applications

8 Global Bone Growth Stimulators Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Ambulatory Surgical Centers (ASCs)
  • 8.4 Home Care Settings
  • 8.5 Other End Users

9 Global Bone Growth Stimulators Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Orthologic Corp.
  • 11.2 Medtronic plc
  • 11.3 Harvest Technologies Corp.
  • 11.4 Amedica Corporation
  • 11.5 Zimmer Biomet Holdings, Inc.
  • 11.6 Smith & Nephew plc
  • 11.7 Orthofix Medical Inc.
  • 11.8 Bone Solutions Inc.
  • 11.9 Bioventus LLC
  • 11.10 Arthrex, Inc.
  • 11.11 Isto Technologies, Inc.
  • 11.12 Stryker Corporation

List of Tables

  • Table 1 Global Bone Growth Stimulators Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Bone Growth Stimulators Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Bone Growth Stimulators Market Outlook, By Bone Growth Stimulation Devices (2022-2030) ($MN)
  • Table 4 Global Bone Growth Stimulators Market Outlook, By Capacitive Coupling Devices (2022-2030) ($MN)
  • Table 5 Global Bone Growth Stimulators Market Outlook, By Combined Magnetic Field Devices (2022-2030) ($MN)
  • Table 6 Global Bone Growth Stimulators Market Outlook, By Implantable Bone Growth Stimulators (2022-2030) ($MN)
  • Table 7 Global Bone Growth Stimulators Market Outlook, By Ultrasonic Bone Stimulators (2022-2030) ($MN)
  • Table 8 Global Bone Growth Stimulators Market Outlook, By Bone Morphogenetic Proteins (BMPs) (2022-2030) ($MN)
  • Table 9 Global Bone Growth Stimulators Market Outlook, By Platelet-Derived Growth Factor (PDGF) (2022-2030) ($MN)
  • Table 10 Global Bone Growth Stimulators Market Outlook, By Other product Types (2022-2030) ($MN)
  • Table 11 Global Bone Growth Stimulators Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 12 Global Bone Growth Stimulators Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 13 Global Bone Growth Stimulators Market Outlook, By Distributors (2022-2030) ($MN)
  • Table 14 Global Bone Growth Stimulators Market Outlook, By Online Retailers (2022-2030) ($MN)
  • Table 15 Global Bone Growth Stimulators Market Outlook, By Pharmacies and Specialty Stores (2022-2030) ($MN)
  • Table 16 Global Bone Growth Stimulators Market Outlook, By Application (2022-2030) ($MN)
  • Table 17 Global Bone Growth Stimulators Market Outlook, By Fractures (2022-2030) ($MN)
  • Table 18 Global Bone Growth Stimulators Market Outlook, By Spinal Fusion (2022-2030) ($MN)
  • Table 19 Global Bone Growth Stimulators Market Outlook, By Dental and Maxillofacial (2022-2030) ($MN)
  • Table 20 Global Bone Growth Stimulators Market Outlook, By Osteoarthritis and Osteoporosis (2022-2030) ($MN)
  • Table 21 Global Bone Growth Stimulators Market Outlook, By Soft Tissue Repair (2022-2030) ($MN)
  • Table 22 Global Bone Growth Stimulators Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 23 Global Bone Growth Stimulators Market Outlook, By End User (2022-2030) ($MN)
  • Table 24 Global Bone Growth Stimulators Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 25 Global Bone Growth Stimulators Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 26 Global Bone Growth Stimulators Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 27 Global Bone Growth Stimulators Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.